Original Source(s)
Related Content
FDA Expands Test for Gastric and Esophageal Cancers
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
July 14, 2026
-
2 min
Side Effects: Bro Science, Actually
Creatine's ATP-buffering trick isn't just for biceps. In mice, it juices up dendritic cells' energy supply, sharpening T-cell priming and shrinking tumors on daily injections. Human DCs got the memo too, at least in a dish. Early days, but a fun plot twist for gym-bag chemistry.
by Kerri Miller
July 8, 2026
-
6 min
Prehabilitation Program May Benefit Patients Undergoing CRC Surgery
Structured implementation increased participation and improved preoperative fitness, while postoperative complication and mortality rates remained similar across groups.
June 25, 2026
-
4 min